Microsoft word - spector cv -complete.doc

CURRICULUM VITAE
SHELDON L. SPECTOR, M. D.
Personal History
Office Address
California Allergy and Asthma Medical Group11645 Wilshire Blvd., Suite 1155Los Angeles, CA 90025(310) 966-9022Fax: (310) 966-9042 Present Position
Clinical Professor, Department of MedicineUCLA School of Medicine, Los Angeles, California Associated with Antelope Valley Allergy Medical Group41230 11th Street West, Suite APalmdale, CA 93551 Consultant for Garrison Family Practice Group41210 11th Street West, Suite A & CPalmdale, CA 93551 Consultant for Edralin Pediatrics1037 West Avenue North, Suite 202Palmdale, CA 93551 Education
Undergraduate:University of Michigan - Ann Arbor, Michigan Department of Zoology, University of Michigan Medical:Summer Fellow, Michigan Heart Association, Wayne State UniversitySchool of Medicine, Detroit, MI (Laboratory of Dr. Walter Seegers) Extern, Highland Park General Hospital, Highland Park, Michigan Wayne State University (M.D.) - Detroit, Michigan *One year spent as USPHS Research Fellow, L'hopital BroussaisParis, France (Professor B.N.Halpern) Sheldon L. Spector, M.D.
Bibliography - 2 Medicine: Mount Sinai Hospital, New York, NY Curriculum Vitae – Sheldon Spector, M.D.
Continued – P 2 Education (cont’d)
Internal Medicine: Mount Sinai Hospital , New York, NY Research Investigator, Laboratory of Virology & Rickettsiology,DBS, National Institutes of Health Internal Medicine, Resident II, UCLA, Los Angeles, CA Allergy & Clinical Immunology, National Jewish Hospital, Denver, CO Military Service
Commissioned Officer, U.S. Public Health Service, Bethesda, MD Specialty Board Certifications
American Board of Internal Medicine, #33977 American Board of Allergy & Immunology, #976 Professional Positions Held
1.
Mount Sinai Hospital School of Medicine - New York CityAssistant in Medicine National Jewish Hospital - Denver, Colorado Clinical Coordinator, Department of Allergy & Clinical Immunology Head, Section of Allergy & Clinical Immunology Representative to Governing Council - Denver Medical Society UCLA School of Medicine - Los Angeles, California Diplomate, National Board of Medical Examiners Member, Editorial Board, Internal Medicine for the Specialist Peer Reviewer, Board of Medical Quality Assurance, State of California Member, Editorial Board, Annals of Allergy, Asthma and Immunology Pulmonary/Allergy Drugs Advisory Committee, Food & Drug Administration Sheldon L. Spector, M.D.
Bibliography - 3 Member, Editorial Advisory Board, Respiratory Review Member, Editorial Board, Journal of Compliance in Health Care Member, Medical Services Review Committee, Los Angeles Co.Med.Assn.
Curriculum Vitae – Sheldon Spector, M.D.
Continued – P 3 Professional Positions Held (cont'd)
13.
American Academy of Allergy and Immunology, Chairman Elect of Interest Section for Asthma, Co-Chairman of Task Force on Practice Parameters Member, Editorial Board, Journal of Asthma, Alternate Delegate, California Medical Society House of Delegates Associate Editor, Consultant and AuthorInternal Medicine Alert, American Health Consultants Medical Advisory Board Member, Allergy and Asthma NetworkMothers of Asthmatics, Inc.
Member, National Faculty of The Core Content Review of Family Medicine Co-Editor, The Epitomes, The Western Journal of Medicine Visiting Professorships
The Hebrew University of Jerusalem, Israel Honors and Special Lectureships
Lady Davis Post-doctoral Fellow in Allergy, Hebrew University, Israel Original Research Award, William Beaumont Society Wayne State University School of Medicine, Detroit, Michigan President, William Beaumont SocietyL. E. Smith LecturerVolunteer Clinical Faculty Award, American Academy of Allergy and Immunology American College of Allergy and Immunology Outstanding Alumnus Award, Wayne State University School of Medicine Sheldon L. Spector, M.D.
Bibliography - 4 American Academy of Allergy and Immunology The Meritorious Service Medal, Colonel, U.S. Army Reserve Major Scientific Interests
VirologyAllergy and Clinical Immunology, especially research Curriculum Vitae – Sheldon Spector, M.D.
Continued – P 4 Professional Societies & Committees
1.
American Association for the Advancement of Science: Member American Academy of Allergy and Immunology Co-Chairman: First Refresher Course in Allergy &Immunology Chairman: Task Force on Practice Parameters American College of Allergy & Immunology (formerly American College of Allergists) Member, Scientific & Education Council Chairman, Scientific Committee on Pregnancy Chairman, Professional Education Committee Steering Committee Section on Allergy and Clinical Immunology Chairman, Section on Allergy and Clinical Immunology Chairman, Forum on Infection & Immunology Sheldon L. Spector, M.D.
Bibliography - 5 Scientific Assembly on Allergy/Clinical Immunology Curriculum Vitae – Sheldon Spector, M.D.
Continued – P 5 Professional Societies and Committees (cont'd)
10.
California Society of Allergy & Clinical Immunology American Medical Association: Consultant for AMA Drug Evaluations Medical Advisory Committee to the Poison Control Center The Bay District Pulse: Bay District Officer Indian Academy of Allergy: Honorary Life Member Task Force on Practice Parameters for the AAAAI, ACAAI and Joint Council American College of Allergy Occupational Asthma Committee USP Council of Experts Pulmonary Disease and Allergy Expert Committee Advisor, US Pharmacopacia, Pulmonary Division Sheldon L. Spector, M.D.
Bibliography - 6 Present Hospital Affiliations
UCLA - Los Angeles, CACedars Sinai Medical Center - Los Angeles, CASt. John's - Santa Monica, CADaniel Freeman Hospital - Inglewood, CASanta Monica UCLA Medical Center – Los Angeles, CABarlow Respiratory Hospital - Los Angeles, CABrotman Memorial Hospital - Culver City, CA Licensures
Halpern BN, Neveu T, Spector SL: On the nature of the chemical mediators involved in anaphylactic reactions inmice. Brit J Pharmacol 1963; 20:389.
Tauraso NM, Spector SL, Jahnes WG, Shelokov A: Yellow fever vaccine: I. Development of a vaccine seed fromcontaminating avian leukosis viruses. Proc Soc Exp Bio Med 1968; 127:111-20.
Spector SL, Tauraso NM: Yellow fever virus: I. Development and evaluation of a plaque neutralization test. AppMicrobiol 1968; 16:1770-75.
Tauraso NM, Spector SL, Kirschstein RL, Seligman EB Jr, Farber JF: Yellow fever vaccine: II. Antigenicity andneurovirulence of a vaccine seed from avian leukosis virus. App Microbiol 1969; 17:866-70, 1969.
Spector SL, Tauraso NM: Yellow fever virus: II. Factors affecting the plaque neutralization test. App Microbiol1969; 18:736-43.
Nossel HL, Niemetz J, Waxman S, Spector SL: Defibrination syndrome in a patient with chronic thrombocytopenicpurpura. Amer J Med 1969; 46:591-98.
Spector SL, Farr RS: Comments on bronchial inhalation provocative tests. J Allergy Clin Immunol 1971; 48:120-22.
Tauraso NM, Pedreira FA, Spector SL, Bernier GM: Effect of various methods of removing non-specific inhibitors tovirus hemagglutination upon serum proteins and immunoglobulins. Arch fur die gesamet Virusforschung 1971;34:214-22.
Tauraso NM, Spector SL, Trimmer RW: Yellow fever vaccine: III. Antibody response in monkeys inoculated with avaccine free from contaminating avian leukosis virus. Arch fur die gesamet Virusforschung 1972; 37:1-61.
Tauraso NM, Coultrip RL, Legters LJ, Richman AV, Rosenberg DM, Savadge TO, Shelokov A, Spector SL,Trimmer RW: Yellow fever vaccine: IV. Reactogenicity and antibody response in volunteers inoculated with avaccine free from contaminating avian leukosis virus. Proc Soc Exp Bio Med 1972; 139:439-46.
Farr RS, Kopetzky MT, Spector SL, Hurewitz DS: Asthma without wheezing. Chest 1973; 63:64S-68S.
Sheldon L. Spector, M.D.
Bibliography - 7 Kinsman RA, Luparello TJ, O'Banion K, Spector SL: Multidimensional analysis of the subjective symptomatology ofasthma. Psychosom Med 1973; 35:250-67.
Spector SL, English G, McIntosh K, Farr RS: Adenovirus in the sinuses of an asthmatic with apparent selectiveantibody deficiencies. Amer J Med 1973; 55:227-31.
Kinsman RA, O'Banion K, Resnikoff P, Luparello TJ, Spector SL: Subjective symptoms of acute asthma withheterogeneous sample of asthmatics. J Allergy Clin Immunol 1973; 52:284-96.
Spector SL, Farr RS: Bronchial inhalation procedures in asthmatics. Med Clin North Am 1974; 58:71-84.
Kinsman RA, Spector SL, Shucard DW, Luparello TJ: Observations on patterns of symptomatology of acute asthma.
Psychosom Med 1974; 36:129.
Spector SL, Katz FH, Farr RS: Troleandomycin: Effectiveness in steroid dependent asthma and bronchitis. J AllergyClin Immunol 1974; 54:367-69.
Spector SL, Farr RS: A comparison of methacholine and histamine inhalations in asthmatics. J Allergy Clin Immunol1975; 56:308-16.
Stein MR, Spector SL: Cardiac response to repeated doses of isoproterenol aerosol. Ann Int Med 1975; 83:908-9.
Spector SL, Luparello TJ, Kopetzky MT, Souhrada JF, Kinsman RA: Response of asthmatics to methacholinechallenge and suggestion. Am Rev Respir Dis 1976; 113:43-50.
Spector SL, Farr RS: Atopy reconsidered. Clin Allergy 1976; 6:83-90.
Chai H, Farr RS, Froelich LA, Mathison DA, McLean JS, Rosenthal RR, Sheffer AL II, Spector SL, Townley RG:Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56:323-27.
Spector SL: Modern management of asthma and bronchitis. Comprehensive Therapy 1976; 2:26-35.
Spector SL, Farr RS: The heterogeneity of asthmatic patients - an individualized approach to diagnosis and treatment.
J Allergy Clin Immunol 1976; 57:499-511.
Hudgel DW, Spector SL: Recurrences of pulmonary infiltration with eosinophilia in an asthmatic treated withbeclomethasone dipropionate. Chest 1977; 72:359-60.
Weinberger M, Hudgel DW, Spector SL, Chidsey C: Inhibition of theophylline clearance by troleandomycin.
J Allergy Clin Immunol 1977; 59:228-31.
Horton DH, Spector SL: Clinical pulmonary tuberculosis in an asthmatic patient using a steroid aerosol. Chest 1977;71:540-42.
Spector SL, Hudson L, Petty TL: Effect of Bronkosol and its components on cardiopulmonary parameters inasthmatic patients. J Allergy Clin Immunol 1977; 59;371-76.
Spector SL, Garza-Gomez J: Dose-response effects of albuterol aerosol compared with isoproterenol and placeboaerosols. J Allergy Clin Immunol 1977; 59:280-86.
Kinsman RA, Dahlem NW, Spector SL, Staudenmayer H: Observations on subjective symptomatology, copingbehavior and medical decisions in asthma. Psychosom Med 1977; 39:102-19.
Sheldon L. Spector, M.D.
Bibliography - 8 Dirks JF, Kinsman RA, Jones NF, Spector SL, Davidson PT, Evans NW: Panic fear, a personality dimension relatedto length of hospitalization in respiratory illness. J Asthma Research 1977; 14:61-72.
Reich S, Early W, Raven T, Goodman M, Spector S, Stein M: Evaluation of gastropulmonary aspiration by aradioactive technique. J Nuc Med 1977; 18:1079-81.
Norris DA, Fine R, Weston WL, Spector SL: Monocyte cellular function to asthmatics on alternate day steroidtherapy. J Allergy Clin Immunol 1978; 61:255-60.
Horton DJ, Suda WL, Kinsman RA, Souhrada J, Spector SL: Bronchoconstrictive suggestions in asthma: A role forairways hyperreactivity and emotions. Am Rev Respir Dis 1978; 117:1029-38.
Simpson DL, Goodman M, Spector SL, Petty TT: Long-term follow-up and bronchial reactivity testing in survivorsof the adult respiratory distress syndrome. Am Rev Respir Dis 1978; 117:449-54.
Spector SL: Effect of beta adrenergic agents on skin test response and bronchial challenge responses. Chest 1978(Suppl); 73S:976-77S.
Weinstein AM, Dubin BD, Podlesky WK, Spector SL, Farr RS: Asthma and pregnancy. JAMA 1979; 241:1161-65.
Spector SL, Staudenmayer H, Kinsman RA, Fukuhara J, Westmoreland C: Methacholine and histamine inhalationchallenges in asthma: Relationship to age of onset, length of illness, and pulmonary function. Allergy 1979; 34:167-73.
Spector SL: Asthma: Current pathophysiologic and therapeutic aspects. Hospital Medicine 1979; 15:80 83.
Spector SL: Computer oriented characteristics of the asthmatic patient. International Journal on Tissue Reactions.
1979, December; 1:No.3-4.
Farr RS, Spector SL, Wangaard C: Asthma and non-steroidal anti-inflammatory drugs. Ann Int Med 1979; 89:577-78.
Staudenmayer H, Kinsman RA, Dirks JF, Spector SL, Wangaard C: Medical outcome in asthmatic patients: Effectsof airway hyperreactivity and symptom-focused anxiety. Psychosom Med 1979; 41:109-18.
Spector SL: Use of provocation techniques for the evaluation of drug efficacy. J Allergy Clin Immunol 1979;64:677-84.
Spector SL, Kinsman RA: More implications in reactivity characteristics of asthmatic patients to methacholine andhistamine. J Allergy Clin Immunol 1979; 64:587-89.
Spector SL, Farr RS: Bronchial inhalation challenge with antigen. J Allergy Clin Immunol 1979; 64:580-86.
Jones LM, Spector SL, English GM, Taylor-Dawson K: Treatment of perennial rhinitis and flunisolide corticosteroidspray. Ann Allergy 1979; 42:139-44.
Farr RS, Spector SL, Wangaard CH; Evaluation of aspirin and tartrazine idiosyncrasy. J Allergy Clin Immunol 1979;64:667-68.
Spector SL, Wangaard CH, Farr RS: Aspirin and concomitant idiosyncrasies in adult asthmatic patients. J AllergyClin Immunol 1979;64:500-06.
Sheldon L. Spector, M.D.
Bibliography - 9 Nathan RA, Kinsman RA, Spector SL, Horton DJ: Relationship between airways response to allergens andnonspecific bronchial reactivity. J Allergy Clin Immunol 1979; 64:491-99.
Spector SL: Management of chronic symptoms in the asthmatic patient. Hospital Medicine 1979; 15:16 26.
Spector SL: Effect of a selective beta-2 adrenergic agonist and theophylline on skin test reactivity and cardiovascularparameters. J Allergy Clin Immunol 1979; 64:23-28.
Rosenthal RR, Chai H, Mathison DA, Spector SL, Townley RG: Indications for inhalation challenge. J Allergy ClinImmunol 1979; 64:603,.
Spector SL, English G, Jones L: Clinical and nasal biopsy response to treatment of perennial rhinitis. J Allergy ClinImmunol 1980; 66:129-37.
Spector SL, Farr RS: Managing asthmatic patients during pregnancy. J Resp Dis 1980; 1:55-59.
Szefler SJ, Rose JW, Ellis EF, Spector SL, Green AW, Jusko WJ: The effect of troleandomycin onmethylprednisolone elimination. J Allergy Clin Immunol 1980; 66:447-51.
Smith SC Jr, Spector SL: Cardio-selective beta adrenergic therapy in a patient with asthma and hypertrophicobstructive cardiomyopathy. Chest 1981; 80:103-05.
Spector SL, Lotan A, English G, Philpot I: Comparison between transillumination in diagnosing paranasal sinusdisease. J Allergy Clin Immunol 1981; 67:22-26.
Spector SL, Morris HG, Selner JC: Clinical responses and serum prostaglandin levels in aspirin idiosyncrasy: Effectof aspirin and a new nonsteroidal anti-inflammatory agent. Chest 1981; 80:676-81.
Morrill CG, Dickey DW, Weiser PC, Kinsman RA, Chai H, Spector SL: Calibration and stability of standard andMiniWright peak flow meters. Ann Allergy 1981; 46:70-73.
Spector SL: Tolerance to beta adrenergics and results of rising dose studies of albuterol, isoproterenol and placebo(Case Reports). Ann Allergy 1981; 47:394-401.
Labovitz E, Spector SL: Placental theophylline transfer in pregnant asthmatics. JAMA 1982; 247:786 88.
Spector SL, Wangaard C, Bardana EJ Jr: The use of cultures and immunologic procedure to predict oropharyngealcandidiasis in patients on steroid aerosols. Clin Allergy 1982; 12:269-78.
Szefler SJ, Ellis EF, Brenner M, Rose JQ, Spector SL, Yurchak AM, Andrews F, Jusko WJ: Steroid-specific andanticonvulsant interaction aspects of troleandomycin-steroid therapy. J Allergy Clin Immunol 1982; 69:455-60.
Spector SL, Toshener D, Gay I, Rosenman E: Beneficial effects of propylene and polyethylene glycol and saline inthe treatment of perennial rhinitis. Clin Allergy 1982; 12;187-96.
Spector SL: Idiosyncratic reactions to aspirin in adult asthmatics and bronchitics. Int Med Specialist 1982; 3:69-75.
Spector SL, Labovitz E: Transplacental theophylline transfer. BronkoScope Curr Concept Pulm Med 1982; 1:6-7.
Phung ND, Kubo RT, Spector SL: Alpha-1-antitrypsin deficiency and common variable hypo-gammaglobulinemia ina patient with asthma. Chest 1982; 81:112-15.
Spector SL: Oral and inhaled drugs in asthma: A current reappraisal. Immunol Allergy Prac 1983; 5:63-70.
Sheldon L. Spector, M.D.
Bibliography - 10 Perry GB, Chai H, Dickey DW, Jones RH, Kinsman RA, Morrill CB, Spector SL, Weiser PC: Effects of particular airpollution on asthmatics. Am J Pub Health 1983; 73:50-54.
Klein JJ, Lefkowitz MS, Spector SL, Cherniack RM: Relationship between serum theophylline levels and pulmonaryfunction before and after inhaled beta agonist in "stable" asthmatics. Am Rev Respir Dis 1983; 127:413-16.
Spector SL: The treatment of the asthmatic mother during pregnancy and labor. Ann Allergy 1983; 51;173-78.
Arbesman C, Bernstein IL, Bierman CW, Bocles JS, Katz R, Lieberman PL, Mattuci K, Meltzer EO, MiddletonE, Noyes J, Pearlman DS, Pence HL, Slavin RG, Spector SL: Multicenter double-blind, placebo-controlled trial offluocortin butyl in perennial rhinitis. J Allergy Clin Immunol 1983; 71:597-603.
Nelson HS, Spector SL, Whitsett TL, George RB, Dwek JH: The bronchodilator response to inhalation of increasingdoses of aerosolized albuterol. J Allergy Clin Immunol 1983; 72:371-75.
Spector SL: A comparison between beta agonists and theophylline in the treatment of asthma. Immunol AllergyPract 1984; Vol.VI, #3: 82/91, 17/26.
Spector SL: Controversial and unproven techniques. Position statement from the ACCP Section on Allergy andClinical Immunology. Chest 1984; 86;132-33.
Spector SL: Bronchial challenge tests: Practical help in asthma. J Respir Dis 1984; 5:106-20.
Spector SL: The use of corticosteroids in the treatment of asthma. Chest 1985; 87:73S-79S.
Shucard DW, Spector SL, Euwer BA, Cummins KR, Shucard JL, Friedman A: Central nervous system side effects ofantiasthma medication - an EEG study. Ann Allergy 1985; 54:177-84.
Spector SL: Advances in the treatment of bronchial asthma. Comprehensive Therapy 1985; 11:13-20.
Spector SL: Advantages and disadvantages of 24-hour theophylline. J Allergy Clin Immunol 1985; 76:302-11.
Spector SL: Is your asthmatic patient really complying? Ann Allergy 1985; 55:552-56.
Spector SL: Physiologic changes that occur in response to allergen induced challenge. Clin Rev Allergy 1985; 3:463-86.
Spector SL: Psychological factors in asthma. Prac Cardiology 1986; 12:150-59.
Spector SL, Kinsman R, Mawhinney H, Siegel SC, Rachelefsky GS, Katz RM, Rohr AS: Compliance of patientswith asthma with an experimental aerosolized medication: Implications for controlled clinical trials. J Allergy ClinImmunol 1986; 77:65-70.
Rohr AS, Spector SL, Rachelefsky GS, Katz RM, Siegel SC: Efficacy of parenteral albuterol in the treatment ofasthma and a comparison of its metabolic side effects with subcutaneous epinephrine. Chest 1986; 89:348-51.
Katz RM, Rachelefsky GS, Siegel SC, Spector SL, Rohr AS: Twice daily beclomethasone dipropionate in thetreatment of childhood asthma. J Asthma 1986; 23:1-7.
Rachelefsky G, Rohr A, Katz R, Wo J, Gracey V, Spector S, Siegel S, Mickey MR: Sustained-release theophyllinepreparations in asthmatic children. Amer J Dis Child 1986; 140:336-40.
Sheldon L. Spector, M.D.
Bibliography - 11 Rachelefsky GS, Wo J, Adelson J, Mickey MR, Spector SL, Katz RM, Siegel SC, Rohr AS: Behavior abnormalitiesand poor school performance due to oral theophylline usage. Pediatrics 1986; 78:1133-38.
Rohr AS, Spector SL, Siegel SC, Katz RM, Rachelefsky GS: Correlation between A-mode ultrasound andradiography in the diagnosis of maxillary sinusitis. J Allergy Clin Immunol 1986; 78:58-61.
Goldsobel A, Siegel SC, Spector SL, Katz RM, Rachelefsky GS, Rohr AS, Drayton G, Indianer L, Peter JB,Barr RJ, Gracey VL: Efficacy of doxepin in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol1986; 78:867-73.
Rachelefsky GS, Rohr AS, Wo J, Gracey V, Spector SL, Siegel SC, Katz RM, Mickey MR: Use of a tube spacer,Aerochamber, to improve the efficacy of a metered dose inhaler in asthmatic children. Amer J Dis Child 1986;140:1191-93.
Mawhinney H, Spector SL: Optimum management of asthma in pregnancy. Drugs 1986; 32:178-87.
Spector SL, Chairperson: Workshop 6: Compliance factors. Report of American Academy of Allergy andImmunology Task Force for Clinical Investigation of Nonbronchodilator Antiasthmatic Drugs. J Allergy ClinImmunol 1986 (Suppl); 78:529-33.
Spector SL, Perhach JL, Rohr AS, Rachelefsky GS, Katz RM, Siegel SC: Pharmacodynamic evaluation of azelastinein subjects with asthma. J Allergy Clin Immunol 1987; 80:75-80.
Rohr AS, Siegel SC, Katz RM, Rachelefsky GS, Spector SL, Lanier R: A comparison of inhaled albuterol andcromolyn in the prophylaxis of exercise-induced bronchospasm. Ann Allergy 1987; 59:107-09.
Spector SL: Adverse reactions associated with parenteral beta agonists, serum potassium changes. NER Allergy Proc1987; 8:317-21.
Bronsky E, Bucholtz GA, Busse WW, Chervinsky P, Condemi J, Ghafouri MA, Hudson L, Lakshminarayan S,Lockey R, Reese ME, Rennard SI, Segal A, Smolley L, Spector S, Stabelein JJ, Van As, Wilson A: Comparison ofinhaled albuterol powder and aerosol in asthma. J Allergy Clin Immunol 1987; 79:741-47.
English GM, Spector S, Farr R, Carr R: Histopathology and immunofluorescent immunoglobulins in asthmatics withaspirin idiosyncrasy. Arch Otolaryngol Head Neck Surg 1987; 113:377-79.
Kemp JP, Meltzer EO, Orgel A, Welch MJ, Bucholtz GA, Middleton E, Spector SL, Newton JJ, Perhach JL Jr: Adose-response study of the bronchodilator action of azelastine in asthma. J Allergy Clin Immunol 1987; 79:893-99.
Spector SL, Altman R: Cetirizine, a novel antihistamine. Amer J Rhinol 1987; 3:147-49.
Rohr AS, Spector SL: Sinusitis: Pathophysiology, diagnosis, and management. Immunol Allergy Clin No Amer1987; 7:383-91.
Grant JA, Bernstein DI, Buckley CE, Chu T, Fox RW, Rocklin RE, Schoenwetter WF, Spector SL, Stafford CT,Stroh E Jr, Karpenter KM: Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatmentof chronic idiopathic urticaria. J Allergy Clin Immunol 1988; 81:574-79.
Blumenthal MN, Selcow J, Spector SL, Zeiger RS, Mellon M: A multicenter evaluation of the clinical benefits ofcromolyn sodium aerosol by metered-dose inhaler in the treatment of asthma. J Allergy Clin Immunol 1988; 86:681-87.
Spector SL: Bronchial challenge tests: Practical help in asthma. J Respir Dis 1988; 9:96-106.
Sheldon L. Spector, M.D.
Bibliography - 12 Mawhinney H, Kinsman R, Spector SL: The anxiety of asthma: Helping the patient cope. J Respir Dis 1988; 9:39-47.
Adelman DC, Spector SL: Update on asthma therapy. Comprehensive Therapy 1988; 14:67-74.
Rachelefsky GS, Grossman J, Conrad E, Wo J, Kawakami K, Rohr AS, Spector SL, Katz RM, Siegel SC, Ball R,Osur S, Shulan D: Ultraslow release theophylline in the pediatric patient. Pediatr Asthma Allergy Immunol 1988;2:109-115.
Spector SL: Topical intranasal corticosteroid therapy in rhinitis. J Allergy Clin Immunol 1988; 81:984-91.
Quaranta JH,.Rohr AS, Rachelefsky GS, Siegel SC, Katz RM, Spector SL, Mickey MR: The natural history andresponse to therapy of chronic urticaria and angioedema. Ann Allergy 1989; 62:421-424.
Spector SL: Ocular, nasal and oral cromolyn sodium in the management of non-asthmatic allergic problems. AllergyProc 1989; 10:191-95.
Kemp JP, Furukawa CT, Bronsky EA, Grossman J, Lemanske RF, Mansfield LE, Murphy S, Ratner PH, Reese ME,Spector SL, Tinkelman DG: Albuterol treatment for children with asthma: A comparison of inhaled powder andaerosol. J Allergy Clin Immunol , 1989; 83:697-702.
Adelman DC, Spector SL: Acute respiratory emergencies in emergency treatment of the injured athlete. ClinicsSports Med 1989; 8:71-79.
Spector SL: Outpatient treatment of asthma. Ann Allergy, 1989; 63:591-7.
Goldenhersh MG, Spector SL: Corticosteroid use in pediatric asthma. Am J Asthma Allergy Pediatr 1989; 3:8-18.
Spector SL: Management of chronic idiopathic urticaria. (Epitomes). West J Med, 1989; 150:337.
Spector SL: Asthma as an inflammatory disease: A look at the evidence. J Respir Dis, 1989; 10(Suppl):S13-S18.
Tinkelman DG, Bucholtz GA, Kemp JP, Koepke JW, Repsher LH, Spector SL, Storms WW, Van As A: Evaluationof the safety and efficacy of multiple doses of azelastine to adult patients with bronchial asthma over time. Am RevRespir Dis, (in press) 1990.
Tinkelman DG, Brandon ML, Grieco M, Hudson L, Rosenthal RR, Spector SL, Tashkin D, Votteri B: Comparison ofsafety and efficacy of inhaled pirbuterol with metaproterenol. Ann Allergy 1990; 64:202-206.
Goldenhersh MJ, Rachelefsky GS, Dudley J, Brill J, Katz RM, Rohr AS, Spector SL, Siegel SC, Summanen P, BaronEJ, Feingold S: The microbiology of chronic sinus disease in children with respiratory allergy. J Allergy ClinImmunol 1990; 85:1030-9.
Spector SL, Bronsky E, Chervinsky P, Lotner G, Koepke J, Selner J, Pearlman D, Tinkelman D, Weakley S, AlderferV, Gorder JW, Wilkinson DJ: Multicenter, double-blind, placebo-controlled trial of triamcinolone acetonide nasalaerosol in the treatment of perennial allergic rhinitis. Ann Allergy 1990; 64:300-05.
Spector SL: Patient education guide: Averting "steroidophobia" in asthmatics. J Respir Dis 1990; 11:96-98.
Goldenhersh MJ, Rachelefsky GS, Dudley J, Brill J, Katz RM, Rohr AS, Spector SL, Siegel SC, Summanen P, BaronEJ, Finegold S: The microbiology of chronic sinus disease in children with respiratory allergy. J Allergy ClinImmunol 1990; 85:1030-39.
Sheldon L. Spector, M.D.
Bibliography - 13 Meltzer EO, Orgel HA, Bronsky EA, Furukawa CT, Grossman J, LaForce CF, Lemanske RF Jr, Paull BR, PearlmanDS, Ratner PH, Spector SL, Tinkelman DG, van As A, Rogenes PR: A dose-ranging study of fluticasone propionateaqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology.
J Allergy Clin Immunol 1990; 86:221-30.
Spector SL: Blockage of a "nonspecific" provocational challenge as a model for predicting clinical efficacy. J AllergyClin Immunol 1990; 86:657-59.
Spector SL, Druce HM, Fireman P, Kaiser, H, Meltzer, Eli, Boggs P, Wood CC Paluch EP: Intranasal ipratropiumbromide nasal spray in nonallergic rhinitis: A randomized, double-blind parallel comparison versus placebo:American Academy of Allergy and Immunology;1990;paper in progress Cocchetto DM, Sykes RS, Spector SL: Paradoxical bronchospasm after use of inhalation aerosols: A review of theliterature. J Asthma 1991;28:49-53.
Spector SL: Asthma and Chronic Obstructive Lung Disease: A Pharmacologic Approach. Disease-a-Month 1991;37(1).
Spector SL, Findlay S, Bronsky E, Dockhorn R, Green A, Grossman J, Kaiser H, Pinnas J, Rowe M, Southern L,Tinkelman D, Webb R, Huber F, Garcia J Ph.D., Huang L Ph.D.:Multicenter, Double-Blind, Placebo-ControlledEvaluation Of Once-A-Day Intranasal Administration of Nasacort ® In Patients With Seasonal Allergic Rhinitis. AnnAllergy 1991; Katz RM, Amedee RG, Fireman P, Kohl R, Meltzer E, Monroe E, Simons RE, Slavin RG, Spector SL: NonsedatingAntihistamines: New Uses, Novel Research; J. Respiratory Diseases, April 1991; supplement Cocchetto DM Ph.D., Sykes RS, Spector SL: Paradoxical Bronchospasm After Use of Inhalation Aerosols: A Reviewof the Literature. J Asthma 1991; 28(1) 49-53 Mawhinney H, Spector SL: Noncompliance In Asthma Patients-And How To Address The Problem. Masters inAllergy 1991; Volume 3, #2; 15-17 Mawhinney H, Spector SL, Kinsman RA, Siegel SC, Rachelefsky GS, Katz RM, Rohr AS: Compliance IN ClinicalTrials Of Two Nonbronchodilator, Antiasthma Medications. Annals of Allergy 1991; 66 294-299.
Spector SL: Determination Of Airway Hyperreactivity To Allergens And Other BronchoconstrictiveSubstances;Chapter 4; 1991 Afrasiabi R, Spector SL: Exercise-Induced Asthma: The Physician and Sportsmedicine; vol 19; pp 49-62 Spector SL: Azelastine: Consultant 1991: pp 35-36 Spector SL: A 6-Year-Old with chronic Nasal Congestion: Consultant 1991: pp 19-24 Spector SL: Common Triggers Of Asthma: Symposium: 1991 pp 50-59 Camacho AE, Cobo R, Otte J, Spector SL, Lerner CJ, Garrison NA, Miniti A, Mydlow PK, Giguere GC, Collins JJ:Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterialmaxillary sinusitis: Amer J of Medicine, September 1992, vol 93, Num 3, pp 271-6.
Spector SL: Exercise-induced bronchospasm: Mechanisms and management: J of Resp Dis; vol 13, No.6 supp: June1992 Sheldon L. Spector, M.D.
Bibliography - 14 Greenwald M, Brandli D, Golde G, Spector SL, Silverman S: Corticosteroid-induced osteoporosis: effects of atreatment with slow-release sodium fluoride: Osteoporosis Int; June 1992 Spector SL: The coughing soccer player: Clin Cases in All Dis: Fall 1992, pp 1-4 Casillas AM, Spector SL: Nonsedating antihistamines: An overview: Drug Therapy: August 1992, vol.22, no.8, pp29-35 Spector SL, Raizman MB: Conjunctivitis medicamentosa. J Allergy Clin Immunol: 1994, pp 134-136.
Arlian LG, Bernstein D, Bernstein IL, Friedman S, Grant A, Lieberman P, Lopez M, Metzger J, Platts-Mills T, SchatzM, Spector SL, Wasserman SI, Zeiger RS: Prevalence of dust mites in the homes of people with asthma living ineight different geographic areas of the United States: J Allergy Clin Immunol;September 1992, Vol 90, Num 3, part 1,pp 292-300.
Spector SL, Lee N, McNutt B, Katz RM, Huster W, Siegel SC, Rachelefsky GR, Rohr A: Effect of Terfenadine inAsthmatic Patients: Annals of Allergy, September, 1992, Vol 69, Num 3, pp 212-6.
Spector SL: The role of allergy in sinusitis in adults: J Allergy and Clin Immunol, September , 1992, Vol 90, Num 3,part 2, pp 518-20 Spector SL, : Intranasal anticholinergic treatment of nasal disorders; J Allergy and Clin Immunol, December, 1992,Supplement Vol 90, No. 6, Part 2, Guest Editor Schanker HM, Rachelefsky G, Siegel SC, Katz RM, Spector SL, Rohr AR, Rodriquiz C, Woloshin K, Papanek PJ:Immediate and delayed type hypersensitivity to malathion. Annals of Allergy, December, 1992, Vol 69, Num 6 Mawhinney H, Spector SL, Heitjan D, Kinsman RA, Dirks JF, Pines I: As-Needed Medication Use in Asthma UsagePatterns and Patient Characteristics: J Asthma, 1993: 30 (1), 61-71 Spector SL: Two antibiotics compared in acute bacterial maxillary sinusitis: Today in Med, 1993: 6 (1), 32-33 Bronsky E, Spector SL, Pearlman D, Justus S, Bishop A: Albuterol aerosol versus albuterol rotacaps in exercise-induced bronchospasm in children. Pediatrics (In Press).
Druce HM, Spector SL, Fireman P, Kaiser H, Meltzer EO, Boggs P, Wood CC, Paluch EP: A randomized, double-blind, placebo-controlled, parallel-comparison study of intranasal ipratropium bromide 0.03% administered twice aday in nonallergic perennial rhinitis. Annals of Allergy (In Press) Mahan C, Spector SL, Siegel SC, Rachelefsky GS, Katz R, Rohr A: Validity and reproducibility of multitest skin testdevice. Ann Allergy 1993;71(1):25-28.
Spector SL: Allergic and nonallergic rhinitis: Update on pathophysiology and clinical management. J Clin Phar1993 (In press) Spector S: Introduction, Scientific and Clinical Advances in the Treatment of Allergies: Symposium Presented at theNovember 15, 1992 Meeting of the American College of Allergy and Immunology. Ann Allergy 1993,71:569-570.
Spector S: Update on exercise-induced asthma. Ann Allergy 1993,71:571-577.
Spector S, et al. International Consensus Report on the Diagnosis and Management of Rhinitis. International RhinitisManagement Working Group. Allergy (European Journal of Allergy and Clinical Immunology) 1994,19(49):1-34.
Sheldon L. Spector, M.D.
Bibliography - 15 Spector SL, Smith, LJ, Glass M and the ACCOLATETM Asthma Trialists Group. Effects of 6 weeks of therapy withoral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. Am J Respir CritCare Med 1994,150:618-623.
Corren J, Spector SL. The role of allergy in the treatment of asthma. Current Opinion in Pulmonary Medicine,1995,1:58-64.
Spector S. Allergic and non-allergic rhinitis: update on pathophysiology and clinical management. Amer J ofTherapeutics 1995, 2:290-295.
Bronsky E, Spector S, Pearlman D, Justus S, Bishop A: Albuterol aerosol versus albuterol Rotocaps®, in exercise-induced bronchospasm in children. J of Asthma 1995, 32(3):207-214.
Meltzer E, Spector S (eds): Anticholinergic therapy for allergic and nonallergic rhinitis and the common cold.
Supplement to the J Allergy and Clin Immunol 1995, 95(#5)part 2.
Spector S: The common cold: current therapy and natural history. Supplement to the J Allergy and Clin Immunol1995, 95(#5)part 2:1133-38.
Bernstein IL, Blessing Moore J, Fineman S, Gutman A, Lee RE, Nicklas RA, Pearlman DS, Spector SL (eds).
Establishing practice parameters (editorial). J Allergy and Clin Immunol 1995;96:1-4.
Busse WW, Kiecolt-Glaser JK, Coe C, Martin RJ, Weiss ST, Parker SR (Spector S, et al - participants). Stress andAsthma. NHLBI Workshop Summary. Am J Respir Crit Care Med 1995;151:249-252.
Spector S, Nicodemus CF, Corren J, Schanker H, Rachelefsky G, Katz R, Siegel S: Comparison of thebronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderateasthma. J Allergy and Clin Immunol 1995,96(2):174-181.
Katz R, Friedman S, Diament M, Siegel S, Rachelefsky G, Spector S, Rohr A, Schoettler J, Dorris A: A comparisonof imaging techniques in patients with chronic sinusitis (X-ray, MRI, A-mode ultrasound). Allergy Proceedings1995,16(3):123-127.
Spector S: Implications of Practice Parameters (Guidelines). Allergy Proceedings 1995,16(6): 303-304. . Spector S: Review of the properties and features of ceftibuten: a new orally active antibiotic. Infectious Diseases inClin Practice, 1995;4:(2 Suppl):S113-S123.
Tan R, Spector S: Treatment of allergic conjunctivitis. Practical Allergy & Immunol 1995;10:5:186-192.
Spector S: Leukotriene inhibitors and antagonists in asthma. Annals of Allergy, Asthma & Immunol. 1995;75:463-470.
Fineman S, Spector S, Nicklas R, Bernstein IL, Blessing-Moore J, Strunk R, Gutman A, Pearlman D, Lee, R:Preliminary proposal for Practice Parameters. Annals of Allergy, Asthma & Immunol., 1995;75:482-484.
Bernstein IL, Blessing-Moore J, Fineman S, Gutman A, Lee R, Nicklas R, Pearlman D, Spector S: PracticeParameters for allergy diagnostic testing. Annals of Allergy, Asthma & Immunol., 1995:75(6):543-625.
Spector S, Nicklas R (eds): Practice Parameters for the diagnosis and treatment of asthma. J Allergy & ClinImmunol., 1995; 96(5):707-870.
Sheldon L. Spector, M.D.
Bibliography - 16 Bernstein IL, Spector S, et al: A placebo-controlled multi-center study of Auranofin in the treatment of corticosteroid-dependent asthmatics. J Allergy & Clin Immunol.1996;98:317-24.
Spector S (Executive Editor): Redefining Rhinitis: Consensus Conference Proceedings, Part I. UCLA School ofMedicine, Office of Continuing Medical Education, 1995.
Spector S (Executive Editor): Redefining Rhinitis: Consensus Conference Proceedings, Part II - Practical Guidelinesfor Recognition, Treatment and Prevention. UCLA School of Medicine, Office of Continuing Medical Education,1995.
Spector S, Baraniuk J, Brunton S, Meltzer E: The scope of allergic rhinitis. Dialogues In Redefining Rhinitis,1996;1(1). UCLA School of Medicine, Office of Continuing Medical Education, Sheldon Spector Executive Editor.
Saxon A, Greinneder D, Pearlman D, Quan M, Spector S: Exploring the allergy-asthma connection. Dialogues InRedefining Rhinitis, 1996;1(2). UCLA School of Medicine, Office of Continuing Medical Education, Sheldon SpectorExecutive Editor.
Kemp J, Pearlman D, Tinkelman D, Weiler J, Bernstein D, Busse W, DeGraff A, Diamond L, Dockhorn R, MansfieldL, Pierson W, Seltzer J, Spector S, Goldstein M, Lawrence M, D;Eletto, T: An evaluation of the efficacy and safety ofazelastine in patients with chronic asthma. J Allergy Clin Immunol 1996;97:1218-24.
Baraniuk J, Meltzer E, Spector S: Chronic Airway Diseases: Reassessing the Role of Allergy. (Editor: Bussse W) JResp Disease 1996;17(8)[Supplement:] S1-S56.
Spector S: Management of asthma with zafirlukast: Clinical experience and tolerability profile. Drugs 1996; 52(suppl6):36-46.
Finn A, Spector S: Ipratropium bromide nasal spray 0.03% provides additional relief from rhinorrhea combined withterfenadine in perennial rhinitis patients. Annals of Internal Med 1996, in press.
Spector S: Bronchial inhalation challenge procedures with allergens and other bronchoconstrictor substances. Allergieet Immunologie 1996;28:112-118.
Nicklas R, Bernstein IL, Blessing-Moore J, Fineman S, Gutman A, Lee R, Li J, Berger W, Spector S (eds): Practiceparameters for allergen immunotherapy. J Allergy Clin Immunol 1996;98:1-11.
Schanker HM, Spector SL: Scuba diving in individuals with asthma. Allergy & Asthma Proc Nov-Dec 1996;17(6):311-313.
Bernstein IL, Fink J, Edwards T, Spector S, Storms W, Tashkin D: Oral glucocorticosteroid-sparing effect ofbudesonide administered via Turbuhaler. Chest, in press.
Spector L: Allergic rhinitis. Allergy and Asthma Magazine (Professional Edition). Spring, 1996;5(1)1-3. Health LinePublishing, Inc. Menlo Park, CA.
Spector L: A runny nose - nothing to sneeze at. Allergy and Asthma Magazine (Consumer Edition). Spring,1996;5(1)4-5. Health Line Publishing, Inc. Menlo Park, CA.
Spector S: Overview of comorbid associations of allergic rhinitis. J Allergy Clin Immunol 1997;99:S773-80.
Spector S: Alternative treatments in the patient with intractable asthma. Current Opinion in Pulmonary Medicine1997;3:23-29.
Sheldon L. Spector, M.D.
Bibliography - 17 Spector S: Leukotriene Activity Modulation in Asthma. Drugs 1997 Sep; 54(3):369-384.
Spector S, Fish JE: A new approach: clinical review of zafirlukast (AccolateTM, ICI-204,219). Eur Respir Rev1997;7:46,269-273 Spector S: Treatment of the unusually difficult asthmatic patient. Allergy & Asthma Proc 1997;18:153-155.
Tan R, Spector S: Antileukotriene agents: finding their place in asthma therapy. Contemporary Internal Medicine1997;9(8):46-53.
Spector S: Antileukotrienes - 1997 and beyond. ACI International 1997;9(3):79-82.
Tan R, Spector S: Chronic cough. Comprehensive Therapy 1997; 23(7):467-471.
Tan R, Spector S: Antileukotriene agents in asthma. Science & Medicine 1997;4(4):26-33.
Spector S: The allergy-sinusitis link: treatment of sinusitis with an allergic component. Supplement to HospitalMedicine 1997;33(2S):28-34.
Spector S, et al (Members of the Joint Task Force on Practice Parameters), and Work Group on Atopic Dermatitis:Disease management of atopic dermatitis: a practice parameter. Ann Allergy Asthma Immunnol 1997;79:197-211.
Pollard S, Spector S, Yancey S, et al: Salmeterol versus theophylline in the treatment of asthma. Ann Allergy AsthmaImmunnol 1997;78:457-64.
Tan R, Spector S: Exercise-induced asthma. Sports Med 1998 Jan;25(1):1-6.
Simmons M, Nides M, Kleerup E, Chapman K, Milgrom H, Rand C, Spector S, Tashkin D: Validation of theDoserTM, a new device for monitoring metered-dose inhaler use. Submitted for publication.
Spector S: Using antileukotrienes in asthma therapy. Internal Medicine 1998;19(8):12-23.
Nicklas RA, Bernstein IL, Li JT, Lee RE, Spector S, Dykewicz MS, Fineman S, Berger WE, Blessing-Moore J, Schuller DE (Members of the Joint Task Force on Practice Parameters): The diagnosis and management ofanaphylaxis: a practice parameter. J Allergy Clin Immunol 1998;101(6), part 2.
Spector S, et al (Members of the Joint Task Force on Practice Parameters): Parameters for the diagnosis andmanagement of sinusitis. Supplement to J Allergy Clin Immunol 1998;102(6), part 2.
Dykewicz MS, Fineman S (Editors), Skoner DP (Chair, Workgroup on Rhinitis), Nicklas R, Lee R, Blessing-Moore J,Li JT, Bernstein IL, Berger W, Spector S, Schuller D (Associate Editors): Diagnosis and Management of Rhinitis:Parameter Documents of the Joint Task Force on Practice Parameters in Allergy, Asthma, and Immunology. AnnAllergy Asthma Immunol 1998 Nov(part II of II);81(5) Spector S: Ideal pharmacotherapy for allergic rhinitis; J Allergy Clinical Immunol 1999;pp386-387.
Spector S: Forward. J Allergy Clinical Immunology 1999; p.377.
Bousquet J, Metzger WJ, Spector SL, Townely RG, Wenzel SE, Mygind N: Immunobiology of Asthma and Rhinitis– Pathogenic Factors and Theraputic Options; Current Therapies and Future Prospects for the Concomitant Treatmentof Asthma and Rhinitis. Am J Respir Crit Care Med 1999;160, pp 1782-1787.
Sheldon L. Spector, M.D.
Bibliography - 18 Spector S: Allergic inflammation in upper and lower airways. Ann Allergy Asthma Immunol 1999 Nov;83(5):435-444.
Tan R, Spector S: Diagnostic testing in occupational asthma. Ann Allergy Asthma Immunol 1999 Dec;83(6):587-592.
Bernstein IL, Gruchalla, R, Lee R, Nicklas R, Dykewicz M (Chief Editors), and Shepherd G, Berger W, Fineman S, LiJ, Portnoy J, Schuller D, Spector S (Associate Editors): Disease Management of Drug Hypersensitivity: A PracticeParameter. Ann Allergy Asthma Immunol 1999 Dec;83(6):665-700.
Dykewicz M, Spector S: Sinusitis guidelines, part 1: The diagnostic work-up. J Respiratory Diseases 1999Dec;20(12):825-828.
Garrison N, Spector S, Buffington D, Stafford C, Granito K, Zhang H, Talbot GH: Spafloxacin for the Treatment ofAcute Bacterial Maxillary Sinusitis Documented by Sinus Puncture. Ann Allergy Asthma Immunol 2000 Jan:84(1):63-71.
Spector, SL: Use of Antileukotriene Agents in Asthma Management. Comprehensive Therapy 2000 Spring;26(1):31-38.
Dykewicz M, Spector S: Sinusitis: Making the Diagnosis. Consultant 2000 Mar:40(3):603-606.
Spector SL: The linkage between rhinitis, sinusitis, and asthma. International Journal on Immunorehabilitation 2000May;2(3):58-61.
Spector S: Noncompliance with Asthma Therapy – Are There Solutions? Journal of Asthma 2000;37(5):381-388.
Spector S: Leukotrienes and the mechanism by which the LTRAs block their asthma-related effects. AsthmaManagement – A Postgraduate Medicine Special Report 2000 Sept:6-11.
Wanderer AA, Bernstein IL, Goodman DL, Nicklas RA, Li JT, Berger WE, Dykewicz MS, Fineman SM, Lee RE,Portnoy JM, Schuller DE, Spector SL: The Diagnosis and Management of Urticaria: a Practice Parameter. AnnAllergy Asthma Immunol 2000 Dec(part 2 of 2):85(6):521-544.
Spector SL: The linkage between rhinitis, sinusitis, and asthma. Clinical and Applied Immunology Reviews 12001:229-234.
Spector SL: Safety of antileukotriene agents in asthma management. Ann Allergy Asthma Immunol 2001Jun:86(6):18-23.
Tan RA, Spector SL: Exercise-induced asthma: diagnosis and management. Annals of Allergy, Asthma &Immunology 2002;89: 226-236.
Tan RA, Spector SL: The effectiveness of montelukast in the treatment of cough-variant asthma. Annals of Allergy,Asthma & Immunology 2003;90:131. 226. Spector SL, Tan RA, Otsuji A, Attiah N, Moreno J, Patrimonio L: Topical nebulized montelukast for nasal polyps.
Journal of Allergy and Clinical Immunology 2003;111:S147.
Tinkleman DG, Bronsky EA, Gross G, Shoenwetter WF, Spector SL: Efficacy and safety of budesonide inhalationpowder (Pulmicort turbuhaler) during 52 weeks of treatment in adults and children with persistent asthma. Journal ofAsthma 2003;40(3):225-236.
Sheldon L. Spector, M.D.
Bibliography - 19 Spector SL, Surette ME: Diet and asthma: has the role of dietary lipids been overlooked in the management ofasthma? Annals of Allergy, Asthma, & Immunology 2003 April;90:371-377.
Tan RA, Spector SL: Provocation studies in the diagnosis of occupational asthma. Immunology and Allergy Clinicsof North America 2003;23:251-267.
Knoell DL, Spector SL: Insights from a case study: Minimizing the impact of inadequately controlled moderate tosevere asthma. Care Management 2004 Feb;38-43.
Spector SL et al: Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10days in the treatment of acute bacterial rhinosinusitis. Otolaryngology-Head and Neck Surgery 2004 (in press).
Spector SL: NJH experience with inhaled corticosteroids in severe bronchial asthma. Proceedings of Symposium onRecent Advances in the Treatment of Reversible Obstructive Airway Disease. Denver, Colorado, November 1975,Symposia Specialists, Miami.
Cropp GJA, Bernstein IL, Boushey HA Jr, Hyde RW, Rosenthal RR, Spector SL, Townley RG: Guidelines forbronchial inhalation challenge with pharmacologic antigenic agents. ATS News, Spring 1980.
Middleton E Jr, Jacobs E, Spector SL, McGahee O, Slavin R, Toogood JH: Practical approach to asthmamanagement. Schering Corporation, Kenilworth NJ, 1981.
Spector SL: What you should know about aspirin idiosyncrasy. Modern Medicine 1981; 49:97-104.
Spector SL, Chai H: Bronchial, exercise and oral challenge procedures. Bull New York Acad Med 1981; 57:572.
Chai H, Spector SL: Aerosol and air filter therapy. Bull New York Acad Med 1981; 57:568.
Spector SL, Chairman, Subcommittee Scientific Assembly on Allergy & Immunology: Definition of asthma. ATSNews, Fall 1982, p.5.
Spector SL: The use of inhaled corticosteroid aerosols in the treatment of asthma. Hosp Formul, 18:421-26, 1983.
Spector SL: Use and abuse of corticosteroids in asthma and COPD. New Horizons in Pulmonary Medicine.
Colloquium October 1982, American College Chest Physicians. Schering Corporation, Kenilworth NJ, 1983, pp.4-11.
Spector SL: Bronchodilator strategies in asthma. Proceedings of Symposium on Prevention and management ofbronchospasm: A new advance. Sponsored by Univ. of Rochester School of Medicine and Dentistry. New York,NY, March 1985. J Resp Dis 1985; 4:7-15.
Spector SL: Acute respiratory failure: Triggers and treatment. Proceedings of round able: Complications andcomplexities of managing asthma and COPD, Webb-Waring Lung Institute, Denver, CO, July 1985. J Resp Dis1985; 4:31-34.
Bernstein IL, Norman P, Spector SL (contrib.eds): Bronchial asthma's changing spectrum of treatment. DataCentrium 1986; 3:33-44.
Spector SL: Theo-24: Revisited after 3 years of clinical experience. Respiratory Times 1986; (August): pp.4-5.
Mawhinney H, Spector SL: Asthma management during pregnancy, labor, and lactation. The Female Patient 1986:11:40-44.
Spector SL: Diagnostic challenge: Captopril cough. Allergy Observer 1988; 5:2-7.
Sheldon L. Spector, M.D.
Bibliography - 20 Kattan M, Pratt F, Spector SL: Severe asthma Emergency Handbook. Patient Care 1988; 22:86-111.
Spector SL: Reversible obstructive airways disease across the Atlantic: Contrasting treatment in the USA andEurope. In: Inspiration: Development in inhalation therapy. Proceedings of meeting in York, UK October 1988, TheMedicine Group. Symposium series 26, pp. 31-38; Panel discussion, 1989; pp. 48-55.
Spector SL: Psychologic factors in patient compliance. Clinical Advances in Treatment of Allergies, 1989(December):4-12 Spector SL: Asthma: Triggers and treatment. (Dr.'s interview). Medical English (published in Japan) 1989; 6:8-15.
Spector SL: Diagnostic procedures: Skin testing, blood test, and sinus x-rays. The MA Report November 1990.
Spector SL: Newer v Older Single-Agent Antihistamines and Combination Antihistamine-Decongestants. PracticalIssues In Managing Allergic Rhinitis, June 1990:25-31 Spector SL: What Everyone Needs to Know About Exercise-Induced Asthma. Allergy and Asthma Network,Mothers of Asthmatics, Inc., Fairfax, Virginia, 1993.
Spector SL: Clarifying appropriate asthma treatment. The Physician and Sportsmedicine. November 1993;21(11):34-36.
Spector SL: What you should know about steroids for asthma. Patient Education Guide. J Respir Diseases1993;14(10).
Spector SL, et al: Allergy Examiner, "News for the Nose." Vol 1, #1, Fall, 1994.
Korenblat PE, Spector SL, Tremblay NF, Weart CW: New approaches to allergic rhinitis and asthma. Patient Care,October 15, 2000; 108-122.
Spector SL: Methacholine challenge: How long to wait after respiratory infections? J Respir Dis 1989; 10:10-11.
Rachelefsky GS. Spector SL: Sinusitis and asthma. J Asthma 1990; 27:1-3.
Spector SL, et al.: Establishing practice parameters: Parameters for the diagnosis and treatment of asthma. AnnAllergy 1993;71:197-9.
Bernstein IL, Blessing-Moore J, Fineman S, Gutman A, Lee R, Nicklas R, Pearlman D, Spector S: Establishingpractice parameters. J Allergy Clin Immunol 1995, 96(1): 1-4.
Spector SL, Tan RA: Subjective and Objective Markers of Treatment Response in Patients with Seasonal AllergicRhinitis. Ann Allergy Asthma Immunol August 2000, 85(2):87-88.
Letters (Consultative & To/From Editor): Spector SL, Souhrada JF: Maximal midexpiratory flow as an index of acute airway changes. Chest 1975; 68:851-852.
Spector SL: Precautions on the use of alpha-adrenergic antagonists in asthmatic patients. Letters to Editor. N Engl JMed 1979; 301:388-389.
Sheldon L. Spector, M.D.
Bibliography - 21 Letters (Consultative & To/From Editor): Spector SL: Fate of research originally published in abstract. Letters to the Editor. N Engl J Med 1980; 303:130.
Spector SL: Bronchial hyperreactivity to distilled water and saline. Letters to Editor. Br Med J 1982; 284:1117.
Spector SL: No aspirin for asthmatic patients? Clinical Consultation. J Resp Dis 1983; (February) :107-109.
Spector SL, Siegel SC, Katz RM, Rachelefsky GS, Rohr AS: Theophylline dose dumping. Chest 1986; 89:317-18.
Spector SL: Theophylline once-a-day dosage. Communications to the editor. Chest 1986; 90:623-625.
Spector SL, Mawhinney H: More on patient compliance. J Allergy Clin Immunol 1989; 84:409-410.
Mahan C, Spector SL, Siegel SC, Katz RM, Rachelefsky GS, Rohr AS: Multi-test versus Morrow Brown needle.
J Allergy Clin Immunol 1990; 86:275-76.
Mahan C, Spector SL, Siegel SC, Katz RM, Rachelefsky G, Rohr AS: Examine Your Brown Needles. J Allergy ClinImmunol 1991.
11. Spector SL: Oral Steroid Therapy for Asthma and Contact Dermatitis. JAMA 1992; 1926:Vol 12. Spector SL, Mahan C, Siegel SC, Katz RM, Rachelefsky GR: Morrow-Brown Needles Revisited. Spector S, Tan RA: Antileukotrienes in chronic urticaria. J Allergy Clin Immunol 1998; Vol 101:572 Spector, S. Omalizumab: Efficacy in allergic disease. Panminerva Medica 2004;46:00-00.
Spector SL, Garza-Gomez M: Rising dose studies of albuterol, isoproterenol and isoproterenol in patients withbronchial asthma. Proceedings of the Symposium on Recent Advances in The Treatment of Reversible ObstructiveAirway Disease. Denver, Colorado, November 22-23, 1975. Miami, Symposia Specialists.
Farr RS, Spector SL: What is asthma, in The Asthmatic Patient in Trouble. Petty TL (ed) published for UpjohnCompany. Greenwich, CT, CPC Communications, 1976, pp. 639-647.
Farr RS, Spector SL: Medical management of reversible obstructive airway disease. In Recent Advances in AsthmaTherapy. Vanceril Inhaler Brand of Beclomethasone Dipropionate. Miami, Symposia Specialists, 1976, pp. 39-53.
Spector SL: Response of severe corticosteroid dependent asthmatic patients to beclomethasone dipropionate aerosol.
In Recent Advances in Asthma Therapy. Vanceril Inhaler Brand of Beclo-methasone Dipropionate. Miami, SymposiaSpecialists, 1976, pp. 75-80.
Spector SL: Alpha, beta and cholinergic mechanisms in the pathogenesis and treatment of asthmatic patients. InBronches de l'asthmatique, 7th Congres International de Pneumologie, Michel FB (ed), Paris, Masson S.A., 1982, pp.
109-123.
Spector SL: Treating the elderly asthmatic: special considerations. In Clinical Approaches to Bronchodilator Therapy.
Published for Geigy Pharmaceuticals. New York, Biomedical Information Corporation, 1983, pp.23-25.
Spector SL: Bronchodilator strategies in asthma. In New Advances in Bronchodilator Therapy. Alonzo LandsMemorial Symposium, New York, September 1982. Published for Breon Laboratories. Greenwich, CT, CliggottPublishing (publishers of J Respir Dis), 1983.
Sheldon L. Spector, M.D.
Bibliography - 22 Spector SL: (A) Introduction; (B) Compliance with therapy; Steps to help patients; (C) Summary: In After 85 years:New criteria for theophylline therapy. Proceedings of symposium, March 1985, sponsored by University of California,Los Angeles. Greenwich, CT, Cliggott Publishing (publishers of J Respir Dis), 1986, (A - pp.6-7) (B - pp.50-53) (C -p.72).
Spector S: U.S. multicenter trial of cromolyn sodium administered via metered dose inhaler. In Managing asthma inthe 80's: Highlights of a 14-city videoconference. Excerpta Medica, 1986.
Spector SL: The office approach to unusual causes of asthma. In Drug Therapy for Asthma. Jenne JW, Murphy S(eds). New York, Marcel Dekker, Inc., 1987, pp.897-923.
Spector SL: The pharmacology of antihistamines. In Current Pharmacotherapy for Allergic Rhinitis and Urticaria.
Greenwich, CT, Cliggott Publishing (publishers of J Respir Dis), 1987, pp. 24-28.
Spector SL: Newer v Older Single-Agent Antihistamines and Combination Antihistamine-Decongestants. In PracticalIssues In Managing Allergic Rhinitis. (publishers of J Respir Dis), 1990, pp. 25-31.
Spector SL: Relationship between rhinitis / sinusitis and asthma. In Grand Rounds in Allergy, Asthma andImmunology, Part 6 in a series (a CME activity sponsored by The Institute for Medical Studies), June 1996.
Spector SL (Moderator): Sedation and Safety Issues. In Dialogues in Redefining Allergy. 1996 Vol 1(2), ContinuingMedical Education Series developed under the sponsorship of the University of Wisconsin Medical School.
Spector S (editor and senior author): Audio forum: upper respiratory infections (URIs): impact of symptoms, impactof care. Continuing Medical Education program developed by Scientific Exchange, Inc. August 1997.
Spector SL (Moderator): Special Issues in Allergy. In Dialogues in Redefining Allergy. 1997 Vol 2(2), ContinuingMedical Education Series developed under the sponsorship of the University of Wisconsin Medical School.
Spector S: Unusual Bronchial Inhalation Challenges. In Oehling AK, Lopez JG (eds): Progress in Allergy andClinical Immunology, Volume 4, Cancun (Mexico). Proceedings of the XVIth International Congress of Allergologyand Clinical Immunology, Cancun, October 19-24, 1997. Hogrefe & Huber Publishers, Seattle, Toronto, Bern,Gottingen.
Tan R, Spector S: Review of guidelines for the treatment of asthma. Pediatric Rounds: A Focus on AllergicRespiratory Disorders. 1988;6(1):7-8.
Spector S (Faculty Participant): Managing Rhinosinusitis. Consensus Conference Proceedings, Respiratory Infections2000. Sponsored by the University of Wisconsin Medical School and University of Wisconsin School of Pharmacy.
December, 1997.
Nathan RA, Spector SL (contributing editors): Asthma 2000; The Role of Antileukotrienes in Clinical Practice.
Sponsored by the Division of Continuing Medical Education, Discovery International, Deerfield, Illinois. December,1999.
Spector SL, Nash DB: Incorporating Omalizunab into Asthma Treatment Guidelines: Consensus PanelRecommendations: (submitted for approval to the Office of CME Thomas Jefferson Medical College, Philadelphia,PA). April 2003.
Spector SL, Minden P, Farr RS: Surgery in the allergic child . In Gans SL (ed). Surgical Pediatrics. New York:Grune and Stratton, 1973:313-327.
Sheldon L. Spector, M.D.
Bibliography - 23 Spector SL, Kinsman RA, Farr RS: A scheme to characterize asthma . In Stein M (ed). New Directions in Asthma.
Park Ridge, IL: American College of Chest Physicians, 1975:301-315.
Farr RS, Spector SL: Management of the difficult asthmatic. In Stein M (ed). New Directions in Asthma. Park Ridge,IL: American College of Chest Physicians, 1975:438-494.
Spector SL, Farr RS: Bronchial provocation tests. In Weiss EB, Segal MS (eds). Bronchial Asthma Mechanisms andTherapeutics. Boston: Little Brown, 1976:639-647.
Spector SL, Farr RS, Harnett JD: An interface between allergy and otolaryngology. In English GM (ed).
Otolaryngology: A Textbook. Hagerstown, MD: Harper & Row, 1976:291-311.
Harnett JC, Spector SL, Farr RS: Aspirin idiosyncrasy, asthma and urticaria. In Middleton E Jr, Reed CE, Ellis EF(eds). Allergy: Principles and Practice. St. Louis: C V Mosby, 1978:1002-1021.
Spector SL: Prophylaxis of status asthmaticus. In Weiss E (ed). Status Asthmaticus. University Park Press, 1978:327-329.
Spector SL: Asthma in adults. In Conn HF (ed). Current Therapy. Philadelphia: W B Saunders, 1979:547-551.
Spector SL, Farr RS: Aspirin idiosyncrasy: a pseudoallergy. In Franklin EC (ed). Clinical Immunology Update:Review for Physicians. New York: Elsevier North Holland, Inc. 1981:197-226.
Spector SL, Kinsman RA, Farr RS: A profile of the asthmatic patient. In Trautlein JJ (ed). Aerosols, Airways andAsthma. New York: Spectrum Publications, 1981:81-96.
Spector SL: All about asthma. In Norback CT (ed), Slavin RG (consulted). The Allergy Encyclopedia. New York:New American Library, 1981:205-226.
Spector SL, Farr RS: Aspirin idiosyncrasy: asthma and urticaria. In Middleton E, Reed CE, Ellis EF (eds). Allergy:Principles and Practice. St. Louis: C V Mosby, 1983:1249-1273.
Spector SL: Bronchial inhalation challenges with antigens. In Spector SL (ed). Provocative Challenge Procedures:Bronchial, Oral, Nasal and Exercise: Vol.I. Boca Rotan, FL: CRC Press, 1983:97-112.
Spector SL: Bronchial inhalation challenges with aerosolized bronchoconstrictive substances. In Spector SL (ed).
Provocative Challenge Procedures: Bronchial, Oral, Nasal and Exercise: Vol.I. Boca Rotan, FL: CRC Press,1983:137-176.
Spector SL, Farr RS: National Jewish Hospital experience with aspirin, tartrazine, and analgesic oral challenge. InSpector SL (ed). Provocative Challenge Procedures: Bronchial, Oral, Nasal and Exercise: Vol.II. Boca Rotan, FL:CRC Press, 1983:115-118.
Spector SL, Farr RS: The interface between allergy and otolaryngology. In English GM, ed. Otolaryngology,Volume 2. Philadelphia: Harper & Row, 1984:1-26.
Mawhinney H, Spector SL: Asthma in adults. In Edlich RF, Spyker DA (eds). Current Emergency Therapy. NorwalkCT: Appleton-Century-Crofts, 1984:828-833.
Rohr AS, Spector SL: Paranasal sinus anatomy and pathophysiology. In Bierman CW (ed). Clinical Reviews inAllergy. New York: Elsevier-Science Publishing, 1984:2:387-395.
Spector SL: Bronchial provocation tests. In Weiss EB, Segal MS, Stein M (eds). Bronchial Asthma: Mechanisms andTherapeutics (Second edition). Boston: Little, Brown, 1985:360-379.
Sheldon L. Spector, M.D.
Bibliography - 24 Mawhinney H, Spector SL: Asthma in adults. In Edlich RF, Spyker DA (eds). Current Emergency Therapy '85.
Rockville, MD: Aspen Publications, 1985:939-944.
Spector SL: Asthma. In Beall GN (ed). Allergy and Clinical Immunology. New York: John Wiley & Sons,1985:145-186.
Spector SL: Aspirin-induced asthma. In Cherniack RM (ed). Current Therapy of Respiratory Disease -2.
Philadelphia: B.C. Decker, Inc., 1986:106-110.
Mawhinney H, Spector SL: Asthma in adults. In Edlich RF, Spyker DA (eds). Current Emergency Therapy. 3rdedition. Norwalk, CT: Appleton-Century-Crofts, 1986:514-519.
Spector SL: Bronchial provocation tests. In Bousquet J Godard P, Michel F (eds). Highlights in Asthmology. Berlin:Springer-Verlag, 1987:421-430.
Spector SL: The office approach to unusual causes of asthma. In Jenne JW, Murphy S (eds). Drug Therapy forAsthma: Research and Clinical Practice. New York/Basel: Marcel Dekker, 1987:897-923.
Rachelefsky GS, Spector SL: Disorders of the paranasal sinuses. In Bierman CW, Pearlman DS (eds). AllergicDiseases From Infancy to Adulthood. Philadelphia: W.B.Saunders , 1988:476 482.
Spector SL, Sander N (eds): Understanding asthma: A blueprint for breathing. American College of Allergy &Immunology, 1989.
Spector SL (ed): Provocative Challenge Procedures: Background and Methodology. Mount Kisco, NY: FuturaPublishing, 1989.
Spector SL, Mawhinney H: Aerosol inhaler monitoring of asthma medication. In Cramer JA, Spiker B (eds).
Compliance in Medical Practice and Clinical Trials. New York: Raven Press, (in press, 1990) Spector SL: Ocular, Nasal, and Oral Cromolyn Sodium In The Management Of Nonasthmatic Allergic Problems.
Rhinitis - 2nd Edition 1991; Chapter XXVII; 241-246 Afrasiabi R, Spector SL: Exercise-Induced Asthma: The Physician And Sports Medicine. Vol 19; No. 5: May 1991.
Kershaw J, Spector SL: Immunological Diagnosis and Therapy During Pregnancy: Asthma and Allergy in Pregnancyand Early Infancy. 77-88, 1992; Marcel Dekker, Inc.
Spector SL: Bronchial provocation tests. In Weiss EB, Segal MS (eds). Bronchial Asthma Mechanisms andTherapeutics. Bronchial Asthma. Boston: Little Brown, 1993:39.
Spector SL: What everyone needs to know about exercise-induced asthma. Allergy and asthma Network, Mothers ofAsthmatics, Inc. First edition, 1993.
Mawhinney H, Spector S: Management of the pregnant asthmatic. From Bronchial Asthma, M.E. Gershwin, G.M.
Halpen, eds., Humana Press, Tetowa, NJ, January 1994, pp399-412.
Spector SL (ed.): Highlights from a symposium: Advances in the treatment of allergies. Pragmaton Publications,Chicago, 1993.
Spector SL: What Everyone Needs to Know About Exercise-Induced Asthma. Allergy and Asthma Network,Mothers of Asthmatics, Inc., Fairfax, Virginia, 1993.
Sheldon L. Spector, M.D.
Bibliography - 25 Spector SL (Joint Task Force for Practice Parameters): Preliminary Proposal for Practice Parameters. AllergyEvaluation: Appropriate Number of Immediate Hypersensitivity Skin Tests. Published by the American Academy ofAllergy and Immunology and the American College of Allergy and Immunology, March, 1993.
Spector SL, Nicklas RA, Bernstein IL, Blessing-Moore J, Strunk RC, Gutman AA, Pearlman DS, Lee RE, Fineman S(eds): Practice Parameters for the Diagnosis and Treatment of Asthma. 1993. Library of Congress Catalogue Card#93-72193.
Klein G, Mendoza G, Richards W, Spector S, Strunk R, Wynn S, (Contributing Editors). The New Asthma Organizer.
Allergy and Asthma Network, Mothers of Asthmatics, Fairfax, VA, 1994.
Spector SL (ed): Provocation Testing in Clinical Practice. Marcel Dekker, Inc., New York, 1995.
Spector SL: Chapter 34, The Interface Between Allergy and Otolaryngology. In English G (ed) Otolaryngology,Revised Edition - 1995, Lippincott-Raven Publishers, Philadelphia & New York.
Spector S: Review of the properties and features of ceftibuten: a new orally active antibiotic. in Gorbach S (ed)Infectious Diseases in Clinical Practice (supplement), in press.
Spector S: Management of Chronic Asthmatic Symptoms. In Bone RC (series ed). Current Practice of Medicine.
New York: Churchill Livingstone, Inc., 1996:Vol 2;VII:1.1-1.9.
Tsien A, Spector S: Role of Provocation Challenge in Assessing Indoor Air Pollution. In Bardana EJ, Montanaro A(Eds). Indoor Air Pollution and Health. Marcel Dekker, Inc., New York. 1997:387-420.
Tan RA, Spector SL: High-Dose Inhaled Steroids. In William PV (Guest Ed). Immunology and Allergy Clinics ofNorth America. W.B. Saunders Company, Philadelphia, PA. 1996:16(4) 765-776.
Spector SL: Management of Chronic Asthmatic Symptoms. In Bone RC (ed). Current Practice of Medicine (Vol 2).
Churchill Livingston, Inc., Current Medicine, Inc. 1996, Chapter 1.
Mawhinney H, Spector SL: Compliance. in Barnes, Grunstein, Leff, Woolcock (eds). Asthma. Lippincott-Raven,Philadelphia, PA. 1997.
Spector S: Treatments of Exercise-Induced Asthma Other Than β-Agonists. In Weiler JM (ed). Allergic andRespiratory Disease in Sports Medicine. Marcel Dekker, Inc., New York. 1997:159-177.
Mawhinney H, Spector SL: Allergy Diagnosis, Environmental Control, and Immunotherapy During Pregnancy. InSchatz M, Zeiger R, Claman H (eds). Lung Biology in Health and Disease.
Spector SL: Management of Chronic Asthmatic Symptoms. In Lieberman PL (section ed). Allergy and Immunology.
Current Medicine, Inc., 1998;83-92.
Spector SL: Antileukotriene Agents in the Management of Asthma. In Lieberman P, Anderson JA (eds). AllergicDiseases: Diagnosis and Treatment, Second Edition. Humana Press Inc., Totowa, New Jersey. 2000:Chapter 20:361-366.
Tan RA, Spector SL: Allergic Rhinitis. In DeCherney AH, Pregler JP (eds). Women’s Health: Priniciples andClinical Practice. Hamilton, B.C. Decker, 2002:267-279.
Tan RA, Spector SL: Asthma and Exercise. In Weisman IM, Zeballos RJ (eds). Clinical Exercise Testing. Progressin Respiratory Research, Basel, Switzerland. Karger, 2002: 32:205-216.
Tan RA, Spector SL: Provocation Studies in the Diagnosis of Occupational Asthma. In Montanaro A (ed).
Occupational Allergy & Asthma. Immunology and Allergy Clinics of North America. May 2003;23:251-267 Sheldon L. Spector, M.D.
Bibliography - 26 Milgrom E, Spector SL, Usatine R, Tan R (eds): Practical Allergy. Philadelphia, Mosby, 2004.
Spector SL, Tauraso NM: Development of a plague neutralization test for measuring yellow fevervirus antibody. American Society for Microbiology Bacteriological Proceedings, 68th AnnualMeeting 1968; 73:156.
Spector SL, Farr RS: Comparison of varying doses of albuterol and placebo aerosols for the reliefof bronchospasm. J Allergy Clin Immunol 1972; 49:128.
Spector SL, Farr RS: Inhalation challenge in asthmatics. J Allergy Clin Immunol 1973; 51:87.
Spector SL, Farr RS: The use of troleandomycin in steroid dependent asthmatics. J Allergy ClinImmunol 1974; 53:91.
Spector SL, Farr RS: Clinical implications of inhaled methacholine and histamine. Am Rev RespirDis, 1974.
Shucard DW, Spector SL, McCloskey JL: Electroencephalography and anti-asthma medications.
Clin Res, 1974.
Spector SL: A comparison of methacholine and histamine inhalations in asthmatics. Proceedingsof the World Congress on Asthma, Bronchitis and Conditions Allied. New Delhi, India.
November 9-15, 1974.
Spector SL: Idiosyncratic bronchoconstriction following isoproterenol. Proceedings of the WorldCongress on Asthma, Bronchitis and Conditions Allied, New Delhi, India. November 9-15, 1974.
Spector SL, Farr RS: Efficacy of inhaled triamcinolone acetonide vs. placebo in steroid dependentasthmatic patients. Clin Res, 23:1975.
Spector SL, Luparello TJ, Kopetzky MT, Souhrada JT, Kinsman RA: Influence of methacholineand suggestion on asthmatic airways. J Allergy Clin Immunol, February 1975.
Spector SL, Ball RE Jr: Bronchodilating effects of aerosolized SCH 1000 and atropine sulfate inasthmatics. Proceedings of 41st Annual Scientific Assembly, ACCP, Anaheim, California,October 26-30, 1975. Chest, 68:1975.
Garza G, Spector SL: Comparison varying doses of albuterol, isoproterenol and placebo aerosols inasthmatic patients. J Allergy Clin Immunol, 57:Abstract #168, 1976.
Harnett J, Spector SL: Blocking effect of SCH 1000, isoproterenol and the combination ofmethacholine and histamine inhalations. J Allergy Clin Immunol, 57:Abstract #174, 1976.
Weinberger M, Hudgel D, Spector SL, Chidsey C: Troleandomycin (TAO): an inhibitor oftheophylline metabolism. J Allergy Clin Immunol, 57:Abstract #178, 1976.
Spector SL, Farr RS: Comparison of methacholine and histamine inhalations in asthmatics.
O.R.L. Digest, 37:April 1976.
Sheldon L. Spector, M.D.
Bibliography - 27 Spector SL: Beclomethasone dipropionate aerosol in severe steroid dependent asthmatic patients.
Proceedings IX International Congress of Allergology. October 24-30, 1976, Buenos Aires,Argentina.
Spector SL: Aspirin and related idiosyncratic reactions in asthmatic and bronchitic patients. Chest1978; 74:3.
Nathan RA, Kinsman RA, Spector SL, Horton DJ: Comparison of bronchial reactivity to allergensand nonspecific agents. J Allergy Clin Immunol 1979; 63:150. Abst.#51.
Bishop AL, Justus SE, Bronsky E, Pearlman D, Spector SL, Dahiya G, Liddle R: A double-blind, placebo-controlled, crossover trial of albuterol aerosol and albuterol Rotacaps® in children ages 4 through 11 years with exercise-induced bronchospasm (EIB).Amer Acad of All and Immunol, 1992: In Press Spector SL, Morris HG, Selner JC: Pulmonary prostaglandin and clinical response of asthmaticpatients with aspirin idiosyncrasy to a new nonsteroid anti-inflammatory substance compared toaspirin. J Allergy Clin Immunol 1979; 63:154. Abstract #67.
Horton DJ, Spector SL, Morris HG, Selner JC: Tolerance to oral adrenergic agents: comparison ofephedrine and metaproterenol. J Allergy Clin Immunol 1979; 63:159. Abstract #84.
Spector SL, Jones L, English G: Correlation between nasal biopsy and clinical response toflunisolide nasal spray versus placebo. Proceedings of the X International Congress of Allergology,Jerusalem, Israel, November 1979.
Silvers WS, Nathan RA, Spector SL: The influence of aminophylline on cardiac rate and rhythm inasthmatic and normal subjects. Proceedings of the X International Congress of Allergology.
Jerusalem, Israel, November 1979.
Spector SL, Shucard DW: Central nervous system effects of antiasthma medication--an EEG study.
Ann Allergy 1980; 44:48. Abstract #6.
Szefler SJ, Rose JQ, Ellis EF, Spector SL, Green AW, Jusko WJ: Effect of troleandomycin onmethylprednisolone disposition. J Allergy Clin Immunol 1980; 65:181. Abstract #59.
Spector SL, Toshener D, Gay D, Rosenman E: Beneficial effects of propylene and polyethyleneglycol and saline in the treatment of perennial rhinitis. J Allergy Clin Immunol 1980; 65:187.
Abstract #80.
Lotan A, Spector SL, English G, Philpot I: Transillumination vs roentgenogram to diagnoseparanasal sinus disease. J Allergy Clin Immunol 1980; 65:215. Abst.#170.
Klein JJ, DeGroot M, Lefkowitz M, Spector SL, Cherniack RW: Relationship between serumtheophylline levels and pulmonary function before and after inhaled sympathomimetic in "stable"asthmatics. Proceedings 12th International Meeting, Nederlandse, Nord and Belgische ChestPhysicians, Antwerp, Belgium, October 1981.
Szefler SJ, Ellis EF, Brenner M, Roes JQ, Spector SL, Yurchak A, Andrews F, Jusko WJ:Steroid-specific and anticonvulsant interaction aspects of troleandomycin-steroid therapy. J AllergyClin Immunol 1982; 69:130. Abst.#152.
Sheldon L. Spector, M.D.
Bibliography - 28 Katz R, Rachelefsky G, Siegel S, Spector S: Perennial rhinitis treated with FCB. Ann Allergy1982; 48:225. Abstract #5.
Spector S, Katz R, Siegel S, Rachelefsky G, Fitzgerald J, Hardick H, Kinsman R, Dirks R: The useof the nebulizer chronolog as a monitoring device for compliance. Presented, American College ofAllergists, New Orleans 1983, Abstract #32.
Spector SL, Rohr AS, Rachelefsky GS, Katz RM, Siegel SC: Comparison of subcutaneousepinephrine and albuterol in the treatment of acute asthma. J Allergy Clin Immunol 1984; 73:109.
Abstract #1.
Rohr AS, Rachelefsky GS, Siegel SC, Katz RM, Spector SL: Efficacy of "human IgE pentapeptide"in the treatment of allergic rhinitis. J Allergy Clin Immunol, 73:118, 1984, Abstract #37.
LaBralco JM, Reed CE, Rosenthal RR, Shapiro GS, Spector SL, Townley RG: Multicenterevaluation of airways hyperreactivity using a standardized methacholine challenge. J Allergy ClinImmunol 1984; 73:124. Abstract #64.
Katz RM, Rachelefsky GS, Spector SL, Siegel SC, Fitzgerald J: Beclomethasone dipropionate(BDP) as adjunctive to theophylline (T) in chronic asthma of childhood. J Allergy Clin Immunol1984; 73:162. Abstract #216.
Rohr AS, Spector SL, Katz RM, Rachelefsky GS: Comparison of x-ray and ultrasound in thediagnosis of maxillary sinusitis. Ann Allergy 1984; 52:233. Abstract #55.
Rohr AS, Spector SL, Siegel SC, Katz RM, Rachelefsky GS: Rhinoscopy in the evaluation ofrhinitis. NER Allergy Proc 1984; 5:152. Abstract #12.
Rohr AS, Spector SL, Siegel SC, Katz RM, Rachelefsky GS: Comparison of the serum potassium(K+), glucose (G) and EKG changes with subcutaneous (SC) albuterol (ALB) and epinephrine(EPI). Chest 1984; 86:329.
Rachelefsky G, Rohr A, Wo J, Gracey V, Katz R, Spector S, Lefkowitz M, Siegel S: A short termcomparison of two sustained release (SR) theophylline (T) preparations in asthmatic children.
J Allergy Clin Immunol 1985; 75:105. Abstract #1.
Spector SL, Rohr AS, Rachelefsky GS, Katz RM, Siegel SC, Wo J, Gracey V: The effect of foodon once daily Theo-dur® in asthmatic subjects. J Allergy Clin Immunol 1985; 75:105. Abstract #4.
Hoffman M, Kiechel F, Meadows CD, Spector S, Wolf J, Wyatt R: Whole blood/plasma ratiodetermined by a new theophylline test. J Allergy Clin Immunol 1985; 75:128. Abstract #93.
Goldsobel A, Siegel SC, Spector SL, Katz RM, Rachelefsky GS, Rohr AS, Drayton G, Indianer L,Peter JB, Barr RJ, Gracey VL: Efficacy of doxepin in the treatment of chronic idiopathic urticaria.
J Allergy Clin Immun 1985; 75:130. Abstract #103.
Storms W, Middleton E, Dvorin D, Kemp J, Spector S, Newton J, Perhach JL: Azelastine (Azel) inthe treatment of asthma. J Allergy Clin Immunol 1985; 75:167. Abstract #251.
Rohr AS, Rachelefsky GS, Siegel SC, Katz RM, Spector SL: Efficacy of "Human IgEpentapeptide" in the treatment of allergic rhinitis. NER Allergy Proc 1985; 6:271. Abstract #18.
Sheldon L. Spector, M.D.
Bibliography - 29 Spector S, Rohr A, Siegel S, Katz R, Rachelefsky G: Effects of parenteral albuterol administrationon serum potassium and cardiopulmonary parameters in asthmatics. NER Allergy Proc 1985; 6:271.
Abstract #20.
Rachelefsky G, Wo J, Adelson J, Spector S, Katz R, Siegel S, Rohr A: Behavior abnormalities andpoor school performance due to oral theophylline (T) usage. J Allergy Clin Immunol 1986; 77:145.
Abstract #97.
Rohr AS, Siegel SC, Katz RM, Rachelefsky GS, Spector SL, Lanier R: A comparison of albuterol(A) and cromolyn (C) in the prophylaxis of exercise-induced bronchospasm (EIB). J Allergy ClinImmunol 1986; 77:163. Abstract #172.
Siegel SC, Rohr AS, Rachelefsky GS, Katz RM, Spector SL, Wo J, Gracey V: Dose response studyof metered-dose-inhaler (MDI), metaproterenol (MP) for chronic asthma (A) in children. J AllergyClin Immunol 1986; 77:185. Abstract #258.
Katz RM, Rachelefsky GS, Rohr AS, Wo J, Gracey V, Spector SL, Siegel SC: Use of a tubespacer, aerochamber (A), to improve the efficacy of a metered dose inhaler (MDI) in asthmaticchildren. J Allergy Clin Immunol 1986; 77:185. Abstract #260.
Spector S, Rohr A, Rachelefsky G, Katz R, Siegel S, Perhach J, Newton J: Pharmacodynamicevaluation of azelastine in asthmatics. J Allergy Clin Immunol 1986; 77:249. Abstract #513.
Mawhinney Helen, Spector SL, Rohr AS, Rachelefsky GS, Katz RM, Siegel SC: Compliance inclinical trials of two new non-bronchodilator anti-asthmatic drugs. J Allergy Clin Immunol 1986;77:250. Abstract #520.
Blumenthal MN, Selcow J, Spector S, Zeiger RS, Mellon M: Multicenter study of Intal® inhalerMDI in the treatment of asthma. J Allergy Clin Immunol 1986; 77:149. Abstract #115.
Kemp JP, Meltzer EO, Orgel HA, Welch MJ, Lockey RF, Middleton E, Spector SL, Perhach JL,Newton JJ: A dose-response study of the bronchodilator action of azelastine (Azel) in asthma.
J Allergy Clin Immunol 1986; 77:249. Abstract #514.
Quaranta J,.Rohr AS, Rachelefsky GS, Siegel SC, Katz RM, Spector SL: The etiology and naturalhistory of chronic urticaria/angioedema (U/A). J Allergy Clin Immunol 1987; 79:182. Abst #229.
Spector SL, Multicenter Co-investigators: WHR-5029 (triamcinolone acetonide nasal aerosol)versus placebo in perennial allergic rhinitis. Ann Allergy 1987; 58:296. Abstract #71.
Rachelefsky G, Wo J, Kawakami K, Rohr A, Katz R, Siegel S, Spector S: Evaluation of once dailytheophylline (T) in young children with asthma. Syllabus, American College of Allergists Meeting,Boston, November 1987 (Abstract Z, p.201).
Spector SL, Rohr AS, Siegel SC, Katz RM, Rachelefsky GS, Ank B: Comparison of RAST, FASTand FAST-PLUS with skin tests. J Allergy Clin Immunol 1988; 81;230. Abstract #246.
Rohr AS, Siegel SC, Katz RM, Rachelefsky GS, Spector SL, Hudson LD: Comparison of theduration of action of terbutaline (T) and albuterol repetabs (AR). J Allergy Clin Immunol 1988;81:254. Abstract #346.
Bronsky EA, Furukawa CT, Grossman J, Kemp JP, Lemanske RF Jr, Mansfield LE, Murphy SA,Rather PH, Spector SL, Tinkelman DG, Rees ME, Rogenes PR: Albuterol aerosol vs dry powder Sheldon L. Spector, M.D.
Bibliography - 30 (Ventolin Rotacaps®) for treatment of asthma in children. J Allergy Clin Immunol 1988; 81:254.
Abstract #345.
Allen M, Arlian L, Bernstein L, Friedman S, Grant P, Lieberman P, Lopez M, Metzger J, Schatz M,Spector S, Wasserman S: Prevalence of dust mites in the homes of asthmatics in several U.S.
geographic regions. J Allergy Clin Immunol 1988; 81:270. Abstract #408.
Bronsky EA, Furukawa CT, Grossman J, Kemp JP, Lemanske RF, Mansfield LE, Murphy SA,Ratner PH, Spector SL, Tinkelman DG, Reese ME, Rogenes PR: Flow-activated albuterol powdervs albuterol aerosol in children with asthma. American Academy of Pediatrics Meeting, 1988.
Tinkelman DG, Bucholtz G, Kemp J, Repsher L, Spector S, Storms W, Van As A, Koepke J,Freitag J, Perhach J, Hemsworth G: The long term use of azelastine (AZ) in asthmatics. XIIIInternational Congress of Allergology/ Clinical Immunology, Montreux, Switzerland, October1988.
Tinkelman D, Bucholtz G, Kemp J, Repsher L, Spector S, Storms W, Van As A, Koepke J:Evaluation of the safety and efficacy of long term use of multiple doses of azelastine (AZ) inasthmatics. J Allergy Clin Immunol 1988; 81:280. Abstract #449.
Katz R, Friedman S, Diament M, Rohr A, Siegel S, Rachelefsky G, Spector S, Goldenhersh M:A comparison of sinus imagery in chronic sinusitis. J Allergy Clin Immunol 1989; 83:214.
Abstract #170.
Druce HM, Spector SL, Fireman P, Meltzer EO, Kaiser H, Boggs P, Wood CC: Randomized,double-blind, parallel comparison of intranasal Atrovent (A) nasal spray versus placebo innonallergic perennial rhinitis (NAPR). J Allergy Clin Immunol 1989; 83:213. Abstract #168.
Druce HM, Kaiser HB, Weisburg SC, Morris RJ, Spector SL, Fireman P, Meltzer EO, Boggs P, Wood CC: Randomized double-blind comparison of intranasal Atrovent® versus placebo innonallergic perennial rhinitis. Abstract presented at 46th Annual Meeting of American College ofAllergy and Immunology, Orlando FL, 1989. Annals of Allergy: 64(1), 74, 1990.
Druce HM, Spector SL, Fireman P, Kaiser H, Boggs P, Wood CC: Randomized double-blind parallel comparison of intranasal Atrovent® Nasal Spray versus placebo in nonallergic perennialrhinitis (NAPR). Abstract presented at Symposium on Allergy and Infection in the Nose.
Baltimore, MD, June 1989.
Spector S, Greenwald, Golde G, Silverman S: Successful therapy of steroid accentuatedosteoporosis in asthma and COPD. J Allergy Clin Immunol 1989; 83:219. Abstract #189.
Meltzer EO, Bronsky EA, Furukawa CT, Grossman J, LaForce CF, Lemanske RF Jr, Paull BR,Pearlman DS, Ratner PH, Spector SL, Tinkelman DG, van As A: A dose ranging study offluticasone propionate aqueous intranasal spray (FP) in patients with seasonal allergic rhinitis(SAR). J Allergy Clin Immunol 1989; 83:279. Abstract #428.
Findlay S, Bronsky E, Dockhorn R, Green A, Grossman J, Kaiser H, Pinnas J, Rowe M, SouthernL, Spector S, Tinkelman D, Webb R, Huber F, Garcia J: Once-a-day triamcinolone acetonide(TA) nasal aerosol in the treatment of seasonal allergic rhinitis (SAR). J Allergy Clin Immunol1989; 83:278. Abstract #427.
Sheldon L. Spector, M.D.
Bibliography - 31 Spector SL, van As A, Rennard S, Bronsky E, D Cocchetto, MacCosbe P: Double-blindcomparison of controlled-release albuterol as Volmax (V) vs placebo (P) in patients with chronicasthma. Am Rev Respir Dis 1989; 139(suppl):A433.
Spector S, Greenwald M, Silverman SA: Successful treatment of osteoporosis due to steroid-dependent COPD AND asthma. Am Rev Respir Dis 1989; 139(suppl):A16.
Mahan CA, Spector S, Siegel S, Katz R Rachelefsky G, Rohr A: Validity and Reproducibility ofMultitest Skin Test Device.J Allergy Clin Immunol. Lee N,Rachelefsky G, Kobayashi RH, Kobayashi AL, Siegel SC, Katz RM, Spector SL, Rohr AS:Comparison of Efficacy and Safety of Albuterol Administered By Power-Driven Nebulizer (PDN)Versus Metered Dose Inhaler (MDI) With Aerochamber and Mask In Young Children withAsthma. J Allergy Clin Immunol, 1991; 87:307, Abstract #672.
Rachelefsky G, Siegel SC, Katz RM, Spector SL, Rohr AS: Chronic Sinusitis In Children.
J Allergy Clin Immunol, 1991; 87:219, Abstract #320.
Spector S, Lee N, Huster W, McNutt B, Siegel S, Katz R, Rachelefsky G, Rohr A: BronchodilatorActivity of Terfenadine (T), Single And Steady-State B.I.D. Dosing In Allergic Asthmatics.
J Allergy Clin Immunol, 1991; 87:296, Abstract #628.
Rodriguez C, Spector S, Jonathan AM, Lee N, Rohr A, Seigel S, Katz R, Rachelefsky G: Use of ASmell Test In The Assessment Of Nasal Function., 1991; 87:218, Abstract #314.
Siegel S, Lee N, Rohr A, Ank B, Katz R, Rachelefsky G, Spector S, Siegel J: Evaluation OfDermestid Sensitivity In Museum Personnel., 1991; 87:190, Abstract #205.
Schanker H, Spector S: Relationship Between Asthma And Scuba Diving Mortality., 1991;87:313, Abstract #694 Margolskee D, Bodman S, Dockhorn R, Israel E, Kemp J, Mansmann H, Minotti DA, Spector S,Stricker W, Tinkelman D, Townley R, Winder J, Williams V, Rahway NG: The TherapeuticEffects Of Mk-571, A Potent And Selective Leukotriene (LT) D4 Receptor Antagonist, In PatientsWith Chronic Asthma., 1991; 87:309, Abstract #677.
Bronsky E, Pearlman D, Spector SL, Liddle R, Dahiya G, Sykes RS, Bishop AL: The PlaceboEffect In Prevention of Exercise-Induced Bronchospasm (EIB) In Children; First NationalConference on Asthma Management. Oct 11-13, 1992, Arlington, VA. Abstract Bishop A, Justus S, Bronsky E, Pearlman D, Spector SL, Dahiya G, Liddle R: A Double-Blind,Placebo-Controlled, Crossover Trial of Albuterol Aerosol and Albuterol Rotacaps In Children Ages4 Through 11 Years With Exercise-Induced Bronchospasm (EIB); J Allergy Clin Immunol, 1993;91:167, Abstract #105 Klein GL, Spector SL, Brandan M, Heyd A, Echols R: Oral Ciprofloxacin (CIP) Vs CefuoximeAxetil (CA) In the Treatment Of Acute Bacterial Sinusitis: A Pilot Study In Adults.J Allergy ClinImmunol, 1993; 91:167, Abstract #496 Katz R, Siegel S, Rachelefsky GS, Spector SL, Corren J, Schanker H, Patnaik M,: Treatment ofAcute Sinusitis in Adults: J Allergy Clin Immunol, 1993; 91:167, Abstract #494 Sheldon L. Spector, M.D.
Bibliography - 32 Rachelefsky G, Siegel S, Katz R, Spector S, Corren J, Schanker H: Non-Allergic Rhinitis WithEosinophils Syndrome (NARES) In Childhood. J Allergy Clin Immunol, 1993; 91:167,Abstract #230 Schanker H, Spector SL, Kemp, J, Pierson W, D'Amico J, Dean N: A Double-Blind PlaceboControl Evaluation of Repirinast in Attenuation of Antigen Induced Bronchospasm. J Allergy ClinImmunol, 1993; 91:167, Abstract #103 Spector SL: Conjunctivitis Medicamentosa: New Clinical Entity? J Allergy Clin Immunol, 1993;91:167, Abstract #239 Spector SL: Inhaled steroids in severe asthma maintenance: high dose vs. low dose. Int Med Alert,1993; 15:4,25-32 Klein GL, Spector S, Brandan M, Heyd A, Echols R: Oral Ciprofloxacin (CIP) vs CefuroximeAxetil (CA) in the Treatment of Acute Bacterial Sinusitis: A Pilot Study in Adults. J Allergy ClinImmunol, 1993;91(1): 265, Abstract #496 Spector SL, Nicodemus CE, Siegel SC, Katz RM, Rachelefsky GS, Schanker HM, Corren J:Bronchodilating Effect of Cetirizine With and Without Albuterol Metered Dose Inhaler (MDI),J Allergy Clin Immunol, 1994 (93): 271, Abstract #652.
Katz RM, Patnaik M, Siegel S, Rachelefsky G, Corren J, Schanker H, Spector S: The treatment ofAcute Sinusitis in Adults: J Allergy Clin Immunol, 1994;93(1):176, Abstract #84 Creticos PS, Spector SL, Busse WW, Israel E, Nicodemus CF, Jones NH, Olson T, Gefter MA,Lichtenstein LM, Norman PS: Evaluation of T-cell defined peptides from cat allergen by bronchialchallenge. J Allergy Clin Immunol, 1995, in press.
Spector S, Miller CJ, Glass M: 13-week dose-response study with AccolateTM (zafirlukast) inpatients with mild to moderate asthma. Resp. and Critical Care Med, 1995;141(4)A379.
Spector S, et al: Bronchial challenge (BC) response to cat allergen after T cell epitope definedpeptide therapy. Asthma: Theory to Treatment, Abstract Book, a Joint Conference Sponsored by theAAAAI & Amer. Thoracic Soc., July 15-17, 1995.
Spector S, et al: Salmeterol compared with theophylline in the treatment of asthma. Asthma:Theory to Treatment, Abstract Book, a Joint Conference Sponsored by the AAAAI & Amer.
Thoracic Soc., July 15-17, 1995.
Spector S, Miller CJ, Glass M: 13-week dose-response study with AccolateTM (zafirlukast) inpatients with mild to moderate asthma. Allergy (European J Allergy and Clin Immunol),1995;50(26) Abstract#P-0105, pg 117.
Talbot G, Kennedy R, Scheld M, Granito K, and the Zagam®, Endoscopy Study Group, Rhone-Poulenc Rorer Pharmaceutical Corp: Utility of sinus endoscopy versus sinus aspiration formicrobiologic documentation of acute maxillary sinusitis (AMS)., 35th ICAAC, San Francisco,California, in press.
Corren J, Froehlich J, Schoenhoff M, Spector S, Rachelefsky G, Schanker H, Patnaik M, Siegel S:Phase I Study of Anti-IgE Recombinant Humanized Monoclonal Antibody rhuMAB-E25 (E25) inAdults with Moderate to Severe Asthma. J Allergy Clin Immunol, 1996;97(1):245, Abstract #251.
Sheldon L. Spector, M.D.
Bibliography - 33 Rachelefsky G, Adelglass J, Corren J, Spector S, Schanker H, Kiely L, Siegel, S: Evaluation of Safety and Efficacy of DexacortTM Turbinaire®, (DEX) Nasal Spray in Patients with PerennialAllergic Rhinitis. J Allergy Clin Immunol, 1996;97(1):434, Abstract #1005.
Spector S, Corren J, Rachelefsky G, Schanker H, Siegel S: Evaluation of Efficacy and Duration ofAction of Levocabastine (LEVO) Nasal Spray Under Nasal Challenge Conditions. J Allergy ClinImmunol, 1996;97(1):436, Abstract #1015.
DuBois J, Puopolo A, Nolen T, Spector S, Reidenberg B: Once Daily Oral Ceftibuten vs ThreeTimes Daily Co-amoxiclav in Acute Maxillary Sinusitis. ICAAC Abstract, 1996, in press.
Finn A, Korenblatt P, Lumry W, Woehler G, Settipane S, Spector S, Drda K, Wood C: A randomized, double-blind comparison of combined use of ATROVENT® Nasal Spray 0.03% (A) plus Seldane® (S) versus S plus vehicle (V) in patients with allergic and nonallergic perennialrhinitis (APR and NAPR). Am J of Resp Crit Care Medicine 153(4),A525, 1996.
Sahn S, Galant S, Murray J, Bronsky E, Spector S, Faiferman I, Stober P: Pranlukast (UltairTM)improves FEV1 in patients with asthma: results of a 12-week multicenter study vs nedocromil. AmJ of Respir Crit Care Medicine 155(4),A665,1997.
Simmons M, Nides M, Kleerup E, Chapman K, Milgrom H, Rand C, Spector S, Tashkin, D:Validation of the DoserTM, a new device for monitoring metered-dose inhaler use, and comparisonwith the thermistor-based nebulizer chronolog. A m J of Respir Crit Care Medicine155(4),A260,1997. 16 Spector S, et al: Effect of 24-week salmeterol therapy on airway hyperresponsiveness. ALA/ATSInternational Conference, May 17-21, 1997, San Francisco, CA.
Corren J, Spector S, Fuller L, Rachelefsky G, Siegel S, Shanker H, Minkwitz M: Effect ofzafirlukast (Accolate) on pulmonary responses to natural cal allergen exposure. Allergy andAsthma Proceedings 2000 Jan-Feb;21(1):62 Welch MJ, Kane RE, Fite T, Banjeri D, and the US Azmacort Once Daily Study Group: AzmacortHFA (Triamcinolone Acetonide) Inhalation Aerosol Administered Once Daily Is Effective in theTreatment of Mild and Moderate Persistent Asthma. J Allergy Clin Immunol 2000 Jan;104(1)[part2]:S11

Source: http://www.calallergy.com/downloads/spector_cv.pdf